- Home
- EPM vs ABOS Comparison
EPM vs ABOS Comparison
Compare EPM & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- ABOS
- Stock Information
- Founded
- EPM 2003
- ABOS 1996
- Country
- EPM United States
- ABOS United States
- Employees
- EPM N/A
- ABOS N/A
- Industry
- EPM Oil & Gas Production
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- ABOS Health Care
- Exchange
- EPM Nasdaq
- ABOS Nasdaq
- Market Cap
- EPM 169.0M
- ABOS 99.1M
- IPO Year
- EPM 1996
- ABOS 2021
- Fundamental
- Price
- EPM $5.51
- ABOS $1.56
- Analyst Decision
- EPM Strong Buy
- ABOS Strong Buy
- Analyst Count
- EPM 1
- ABOS 3
- Target Price
- EPM $8.25
- ABOS $9.33
- AVG Volume (30 Days)
- EPM 216.5K
- ABOS 379.4K
- Earning Date
- EPM 02-04-2025
- ABOS 11-12-2024
- Dividend Yield
- EPM 8.78%
- ABOS N/A
- EPS Growth
- EPM N/A
- ABOS N/A
- EPS
- EPM 0.14
- ABOS N/A
- Revenue
- EPM $87,172,000.00
- ABOS N/A
- Revenue This Year
- EPM $7.51
- ABOS N/A
- Revenue Next Year
- EPM N/A
- ABOS N/A
- P/E Ratio
- EPM $38.97
- ABOS N/A
- Revenue Growth
- EPM N/A
- ABOS N/A
- 52 Week Low
- EPM $4.59
- ABOS $1.54
- 52 Week High
- EPM $6.29
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- EPM 58.92
- ABOS 30.29
- Support Level
- EPM $5.25
- ABOS $1.69
- Resistance Level
- EPM $5.46
- ABOS $1.88
- Average True Range (ATR)
- EPM 0.14
- ABOS 0.13
- MACD
- EPM 0.05
- ABOS -0.00
- Stochastic Oscillator
- EPM 97.18
- ABOS 4.88
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the United States. It is engaged predominantly in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are generated from its crude oil, natural gas, and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.